Sponsor Pipeline

The Second Affiliated Hospital of Dalian Medical University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06820762 Irinotecan Liposome(II) Combined With Ivonescimab as Second-line Treatment for Small Cell… SCLC Not Yet Recruiting
NCT07349225 Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic… ES-SCLC Not Yet Recruiting
Disease Areas
Small Cell Lung Cancer (2)
Get alerts when The Second Affiliated Hospital of Dalian Medical University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free